Purpose To study the reliability of pulmonary vascular measurements based on computed
tomography (CT) in the prediction of pulmonary hypertension (PH) in patients with advanced …

Introduction Sarcoidosis-associated pulmonary hypertension (SAPH) is associated with
reduced survival in single-centre studies. The international Registry for SAPH (ReSAPH) with …

BACKGROUND: There are relatively few epidemiological studies on interstitial lung disease
(ILD) worldwide. OBJECTIVE: To report the incident cases of ILD and compare our data with …

Background Pulmonary hypertension (PH) is a significant cause of morbidity and mortality
in sarcoidosis. We established a multi-national registry of sarcoidosis associated PH (SAPH) …

Interstitial lung diseases (ILDs) are a heterogeneous group of disorders with varying histologic
appearances characterized by a disruption of the pulmonary parenchyma. 295 Although …

Background Information regarding lung function parameters and functional capacity in renal
failure and post renal transplantation patients with pulmonary hypertension (PH) is limited. …

BACKGROUND: The 6-min walk test (6MWT) is a useful tool to assess prognosis and functional
impairment in various pulmonary diseases. AIMS: To evaluate functional capacity during …

Background: Pulmonary hypertension (PH) is a well-established complication in interstitial
lung disease (ILD) patients. The aim of this study is to investigate the physiological and …

BACKGROUND: Pulmonary hypertension (PH) occurs in many patients with interstitial lung
disease, including sarcoidosis. We explored the frequency, clinical characteristics and …

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a common subtype of interstitial lung
disease (ILD). Information about the associated comorbidities and predictors of survival …